chrisvoncsefalvay/vaers-outcomes huggingface dataset:
administration date=29Jul2021; administration date=14Aug2021; extrem chills; body aches; pain in joints; heavy chest; panic attack; nausea; headache; swollen armpits; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 14Aug2021 12:00 (Batch/Lot number: unknown) at the age of 33 years as dose 2, single for covid-19 immunisation. The patient relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Product: COVID 19, Brand: Pfizer, Lot unknown: True, Lot unknown reason: Other, Lot unknown reason other: do not have card on me, Administration date: 29Jul2021, Administration time: 03:00 PM, Dose number: 1, Vaccine location: Left arm), administration date: 29Jul2021, when the patient was 33 years old, for Covid-19 immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "administration date=29Jul2021; administration date=14Aug2021"; CHILLS (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "extrem chills"; PAIN (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "body aches"; ARTHRALGIA (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "pain in joints"; CHEST DISCOMFORT (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "heavy chest"; PANIC ATTACK (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "panic attack"; NAUSEA (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "nausea"; HEADACHE (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "headache"; SWELLING (non-serious) with onset 14Aug2021 20:00, outcome "unknown", described as "swollen armpits". Additional information Facility type Vaccine was Pharmacy or Drug Store. The patient did not receive any other vaccine in four weeks. The patient did not have Covid prior vaccination. The patient was not Covid tested post vaccination. Adverse event: extrem chills, body aches, pain in joints, heavy chest, panic attack, nausea, headache, swollen armpits  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Examination of the skin reveals about 200 diffuse 2-3 mm papules without vesicles or pustules spread over the trunk and forehead. Developed this non-itching rash 6 days after receiving varicella vaccine. Patient should not receive a second dose of this vaccine. Over the counter symptom relief medications as needed. Return to clinic as needed.
while injecting the Moderna Covid-19 vaccine, the needle fell off and the vaccine went into the intern's left eye; This spontaneous case was reported by a pharmacist and describes the occurrence of OCCUPATIONAL EXPOSURE TO PRODUCT (while injecting the Moderna Covid-19 vaccine, the needle fell off and the vaccine went into the intern's left eye) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced OCCUPATIONAL EXPOSURE TO PRODUCT (while injecting the Moderna Covid-19 vaccine, the needle fell off and the vaccine went into the intern's left eye). On 20-Apr-2021, OCCUPATIONAL EXPOSURE TO PRODUCT (while injecting the Moderna Covid-19 vaccine, the needle fell off and the vaccine went into the intern's left eye) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medication details was reported.
expired dose was administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB59AA, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 4th October 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 4th October 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 04-OCT-2022 Reporter's Comments:  The reporter stated that an expired dose of Bexsero was administered to a patient. The reporter give consent to follow up. Additional Supportive Information: The patient received expire dose of Bexsero which lead to expire vaccine used.
Itchy, warm hives that appeared last night and have since grown to become one large red mound
Woke up early with muscle aches all over the body and strong chills and a painful headache.
4/9/23   I had chest pain. It did not go away so I went to the Emergency Room.  They confirmed I was having a heart attack.  I was airlifted to another hospital after stabilizing me with heparin and nitroglycerin. Once at the other hospital, they continued to give me the same drugs intravenously.  I had an angiogram dissection of SCAD. It revealed I had a very small tear and was too small to stent. I stayed in the hospital for five days for observation. I was discharged with Nitroglycerin, Lipitor and Metoprolol.
This is a spontaneous report from a contactable nurse. A 20-year-old female patient received the first dose of TRUMENBA; NDC number 00005010001 on 25Nov2015, intramuscular, at 0.5 ml single. Medical history included rash (patient went to the dermatologist for a rash a long time ago). The patient's concomitant medications were not reported. The patient experienced severe soreness at the site, fever, nausea, vomiting, general body achiness, all in Nov2015 (within the first 3 days after receiving the first dose of vaccine) and resolved on an unknown date. The events did not require an emergency room or doctor visit. Follow-up (27May2016): New information reported from the same contactable nurse includes reporter's details. Follow-up (24JUL2016): Follow-up attempts are completed. No further information is expected.
pt recv vax 16MAY95 & 18MAY95 pt devel chicken pox w/approx 4 lesions on the arm & hand; pt c/o feeling itchy; pt felt warm w/no measurable fever; pt's brother was vax on the same day & also devel similar sx;
Received vaccine at 12:10 pm on 3/15 1.) Noticed redness of bilateral legs around 2:10pm 3/15    2.) Woke up with epistaxis around 9:30am 3/16; rash on legs appearing petechial now   3.) Gums bleeding morning of 3/17, went to PCP, sent to ER, labs drawn -- > Platelet count of 1
diffuse myalgia starting 1 hour  post vaccine lasting 48 hours  Acute onset sudden left sided weakness started on 10/15 in afternoon. Work up consistent with
Patient had first injection on 3/31/21, and on 4/14/21 patient presented to the ED and was subsequently hospitalized for closed right hip fracture. Patient had second injection on 5/15/21, and on 5/18/21 patient presented to the ED and was subsequently hospitalized for shortness of breath.
My arm hurt for a week after each vaccination shot; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient reported that after every Shingle shot, his/her arm hurts for a week. The patient stated that he/she could not imagine how painful shingles were. The follow-up would not possible as no contact details were available. For tolerance of 2nd dose, refer link case US2021AMR149445.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR149445:Same reporter.
Aches and pains; Fatigue; Fever/My temperature was 99 which "generally" (not clarified) my temperature is usually 97; Arm was extremely painful; Joint pain; Headache; Could not work today because I was not feeling good; This is a spontaneous report from a contactable consumer (patient).  A 63-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot), via an unspecified route of administration, on 13Jan2021 (at the age of 63-years-old) as a single dose for COVID-19 vaccination. Medical history includes heart disorder. Concomitant medication included: Simvastatin, Atenolol, and medicine for my "heart". The patient reported that she received the first dose on 23Dec2021 and stated she had no reaction. On an unspecified date, the patient stated "I could not work today because I was not feeling good from the vaccine. I got it on the 13th I had off some work yesterday so I had a temperature aches and pains, fatigue and I had to call out last night. Today I am running still very slight fever, aches and pains - so it is improving." The first day, I was fine. I got it at the end of the day. The second day my arm was not red or anything but it was extremely painful, joint pain, headache, fatigue and my temperature was 99 (my temperature is usually 97). Today the temperature is lower and that does not hurt as much." The clinical outcome of the events malaise, aches and pain, fatigue, pyrexia, pain in arm, joint pain, and headache was unknown.   No follow-up attempts are possible. No further information is expected.
It hurt momentarily and I stayed for 15 min as required. I went to work at 2pm. At around 8:30pm, I started feeling like I ran a marathon. I felt like I hit a wall. My body just ached. I took some Ibuprofen and continued my shift. I woke up the next day with a headache so bad that I couldn't lift my head off of the pillow. I took Tylenol and that continued the entire day. I stayed in bed all day. The next night, I woke up in the middle of the night with chills, but no temperature. The following Monday, I still had the chills along with nausea. By Tuesday, I felt normal again.
I am also having the side effects; this hurts me really bad; The tissue inside around the bones and in joints it just 'baffled'; I have so much pain I can't move my foot; I have pain in my hip bone; I have pain in my back; I can't hear well; Headache; Ankles swollen; It makes my sugar drop; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received bnt162b2 (COMIRNATY, solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration on an unspecified date (at the age of 72-years) as dose 1, single for covid-19 immunization. Patient had relevant medical history. The patient did not had concomitant medications. The patient also had the side effects from the first shot (Covid Vaccine by Pfizer), this hurts her really bad, the tissue inside around the bones and in joints it just baffled and the patient had so much pain. The patient did not move her foot, had pain in her hip bone and pain in her back. The patient did not hear well and had headache and her ankles was swollen. The patient had the shot for long time and it makes her sugar drop that was common or not. The pain started after a week. The patient should go ahead or not for the second dose that was main thing that the patient want to know. The patient was informed about the Pfizer Medical Information and provided with the (number withheld) and requested to dial the option 3 and informed about timings as 8 AM to 8 PM from Monday to Friday and for Saturday and Sunday timings are 9 AM to 3 PM as per EST. The patient stated, 15Mar2021 and scheduled for second dose on 05Apr2021. Other medications: the patient stated, she took a lot of medications, about 20, she did not know and they need to know where the patient took the vaccine at the place. The patient went lab test: Blood glucose abnormal: drop. The outcome of the events was unknown.   QR Comment: Reason of delay: Daily spike of incoming calls due to COVID19 vaccine.  No follow-up attempts are possible. No further information is expected.
numbness, tingling, and weakness of arm.  Started immediately after vaccination.  Got worse over the next couple of weeks and then has slowly started to get better without intervention
soreness at injection site and sharp headache pain over my right eye that radiated to the back of my head, both started the night of the injection and through the next day
vaccination exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (vaccination exposure during pregnancy) in a 28-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02SJ20-2A and 042L20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (2 drinks/week. Stopped drinking every time I've been pregnant.) on 12-Oct-2014 and Miscarriage (baby stopped growing at 7w1d, identified via ultrasound at 11w3d. Pathology report revealed baby girl had a fatal & severe chromosomal abnormality called Triploidy (3 full sets of chromosomes)) on 17-Jan-2019. Concurrent medical conditions included Hashimoto's thyroiditis (increased TSH levels due to pregnancy). Concomitant products included MAGNESIUM for Headache, IRON for Iron low, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Seasonal allergy, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 18-Sep-2020 and the estimated date of delivery was 25-Jun-2021. On 14-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (vaccination exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy.  On 14-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (vaccination exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Oct-2020, Pregnancy test: positive (Positive) Positive. On 15-Dec-2020, Prenatal screening test: normal (normal) Results were negative for any chromosomal abnormalities.. On 04-Feb-2021, Ultrasound scan: normal (normal) growth normal.. On 12-Mar-2021, Glucose tolerance test: inconclusive (Inconclusive) passed.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The pregnancy history of the patient included 2 prior pregnancy history with 1 live, full term birth on 15-FEB-2020  and one spontaneous abortion on 17 jan 2019. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jan-2021: Internal review on 19-Jul-2021 resulted in updates to the pregnancy details On 13-Apr-2021: Follow up received on 13-Apr-2021 lab data added.
Received chemotherapy on 3/30 and was hospitalized that night with severe nausea, vomiting, abdominal pain and rash.
Vaccine given on 4/26/10, on 4/28 patient presents with red welts on arm, thigh and back. They are itchy and hot to the touch. Also present on injection site, approx size of silver dollar. Also fever, headache, she was restricted to bed on 4/28. 4/29-patient felt better. 5/5/10- feels better, very small red spots still present. Cortisone cream, Zyrtec and Tylenol.
This is spontaneous report from a Pfizer sponsored program. A contactable physician reported that a currently 73-year old female patient of an unspecified ethnicity started to receive clindamycin HCL (manufacture unknown), codeine, PREVNAR, tramadol, ROCEPHIN, LEVAQUIN, with routes of administration, dates, doses and indications unspecified. The patient's medical history and concomitant medications were not reported. The patient was allergic to clindamycin HCL, codeine, LEVAQUIN, PREVNAR, ROCEPHIN, tramadol on an unspecified date. The action taken in response to the events for clindamycin HCL, codeine, PREVNAR, tramadol, ROCEPHIN, LEVAQUIN and outcome of the events were unknown. Pfizer is a marketing authorization holder of clindamycin HCL and was in the reporter's country. This may be a duplicate report if another marketing authorization holder of clindamycin HCL has submitted the same report to the regulatory authorities. Follow-up (30-SEP-2016): Follow-up attempts are completed. No further information is expected.
Within hour left arm started to get sore. Pain and discomfort kept pt up all night. 10/30 did not go to gym class because of discomfort 10/31 spoke to nurse line who advised pt to go to clinic. Went to walk-in clinic and PA tested range of motion and recommended ibuprofen 3 times a day. Ibuprofen did help. On 11/2 went to gym class and it was still uncomfortable to left 5 pounds of weight. Today feeling better. Pharmacist recommended to get regular flu vax going forward.
Warm to touch at injection site; Redness at injection site; rash; Pain at injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm to touch at injection site), RASH (rash), INJECTION SITE PAIN (Pain at injection site), HEADACHE (Headache) and INJECTION SITE ERYTHEMA (Redness at injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced RASH (rash), INJECTION SITE PAIN (Pain at injection site) and HEADACHE (Headache). On 16-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to touch at injection site) and INJECTION SITE ERYTHEMA (Redness at injection site). The patient was treated with TYLENOL for Pain and Headache, at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (Warm to touch at injection site), INJECTION SITE PAIN (Pain at injection site), HEADACHE (Headache) and INJECTION SITE ERYTHEMA (Redness at injection site) outcome was unknown and RASH (rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Received follow up on 14 JUL 2021: TCR  form  provided which contains new Event (Rash) and event outcome.
started to sweat and felt "not right" post injection a few minutes, states has happened several times in past when getting injections. staff assisted to floor and states did lose consciousness for a moment. felt better once in obs, 1517 bp 119/68 hr 83 rr 20 sats 98% on ra. 1530 bp 138/72 hr 67 rr 17 sats 98% on ra. states s/s resolved, stood up with no issues, escorted to personal vehicle with no issues.
Pt recvd vax JUL91 & w/in 48 hrs following vax devel costochondritis & a fever of 103; dx pneumonia; No further details were provided;
Initial report was received from a health care professional on 14 October 2011. A 64-year-old patient had received an intramuscular injection of FLUZONE, lot number UH467AB (site of administration not reported) on 13 October 2011 at 5:00PM and later after the vaccination at 9:00pm, the patient developed shivering, teeth chattering, headache, blurry vision, and vomited twice. The symptoms lasted about 2 hours. No further informational was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Right after vaccinations the pt complained of feeling hot, clammy, and woozy and a light headache, skin color flushed. Pt was sidephhoretic. Pt had blood pressure taken several times until was normal. Pt stated that she felt hot and complained of tingling in both feet. Stated throat felt slightly tight when swallowing. No erythema on right or left arm. Pt stated she felt lightheaded. Pt given Epinephrine and Claritin with samples of Claritin to take home. At 1:25 pt still complained of tingling left arm and left leg but no signs or symptoms of distress. Was discharged per Dr.
and hot to the  touch; light rash all over that was itchy; Large red blotch around injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (light rash all over that was itchy), VACCINATION SITE WARMTH (and hot to the  touch) and VACCINATION SITE ERYTHEMA (Large red blotch around injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced RASH PRURITIC (light rash all over that was itchy). On an unknown date, the patient experienced VACCINATION SITE WARMTH (and hot to the  touch) and VACCINATION SITE ERYTHEMA (Large red blotch around injection site). In January 2022, RASH PRURITIC (light rash all over that was itchy) had resolved. At the time of the report, VACCINATION SITE WARMTH (and hot to the  touch) outcome was unknown and VACCINATION SITE ERYTHEMA (Large red blotch around injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported.  No Treatment medication was reported.  The case was considered to be invalid as there was no identifiable reporter.